22 results on '"Chteinberg, E."'
Search Results
2. The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas
- Author
-
Kouroukli, A.G., Fischer, A., Kretzmer, H., Chteinberg, E., Rajaram, N., Glaser, S., Kolarova, J., Bashtrykov, P., Mathas, S., Drexler, H.G., Ohno, H., Ammerpohl, O., Jeltsch, A., Siebert, R., and Bens, S.
- Subjects
Cancer Research - Published
- 2023
3. Merkelzellkarzinom: kutane Manifestation einer hochmalignen Prä-/pro-B-Zell-Neoplasie?: Neues Konzept zum zellulären Ursprung des Merkelzellkarzinoms
- Author
-
Sauer, C. M., Chteinberg, E., Rennspiess, D., Kurz, A. K., and zur Hausen, A.
- Published
- 2017
- Full Text
- View/download PDF
4. BURKITT LYMPHOMA AND HIGH-GRADE B-CELL LYMPHPHOMA WITH 11q ABBERRATIONS SHARE A TRANSCRIPTIONAL PROFILE RESEMBLING A SUBPOPULATION OF EARLY DARK ZONE CELLS
- Author
-
Di Stefano, G., primary, Chteinberg, E., additional, Loeffler-Wirth, H., additional, Hillebrecht, S., additional, Wagener, R., additional, Abramov, D., additional, Burkhardt, B., additional, Louissant, A., additional, Horn, H., additional, Mottok, A., additional, Oschlies, I., additional, Klapper, W., additional, Schafernak, K., additional, Zhang, Y., additional, Del-Val, C., additional, Rosenwald, A., additional, Binder, H., additional, Ott, G., additional, Leoncini, L., additional, and Siebert, Reiner, additional
- Published
- 2022
- Full Text
- View/download PDF
5. NONCODING RNAs IN BURKITT LYMPHOMA
- Author
-
López, C., primary, Kretzmer, H., additional, Chteinberg, E., additional, Bernhart, S.H., additional, Glaser, S., additional, Patil, P., additional, Ammerpohl, O., additional, Burkhardt, B., additional, Schlesner, M., additional, Hoffmann, S., additional, and Siebert, R., additional
- Published
- 2022
- Full Text
- View/download PDF
6. 868P A DNA methylation classifier to predict recurrence from clear surgical margins
- Author
-
Abou Kors, T., Chteinberg, E., Ammerpohl, O., Siebert, R., Fehn, A., Benckendorff, J., SorRoche, B.P., Talukdar, F.R., Herceg, Z., Arantes, L., Barth, T.F.E., Thomas, J., Kraus, J.M., Ezić, J., von Witzleben, A., Brunner, C., Hoffmann, T.K., Ottensmeier, C.H.H., Kestler, H.A., and Laban, S.
- Published
- 2023
- Full Text
- View/download PDF
7. 005 - BURKITT LYMPHOMA AND HIGH-GRADE B-CELL LYMPHPHOMA WITH 11q ABBERRATIONS SHARE A TRANSCRIPTIONAL PROFILE RESEMBLING A SUBPOPULATION OF EARLY DARK ZONE CELLS
- Author
-
Di Stefano, G., Chteinberg, E., Loeffler-Wirth, H., Hillebrecht, S., Wagener, R., Abramov, D., Burkhardt, B., Louissant, A., Horn, H., Mottok, A., Oschlies, I., Klapper, W., Schafernak, K., Zhang, Y., Del-Val, C., Rosenwald, A., Binder, H., Ott, G., Leoncini, L., and Siebert, Reiner
- Published
- 2022
- Full Text
- View/download PDF
8. 003 - NONCODING RNAs IN BURKITT LYMPHOMA
- Author
-
López, C., Kretzmer, H., Chteinberg, E., Bernhart, S.H., Glaser, S., Patil, P., Ammerpohl, O., Burkhardt, B., Schlesner, M., Hoffmann, S., and Siebert, R.
- Published
- 2022
- Full Text
- View/download PDF
9. Targeted whole-viral genome sequencing from formalin-fixed paraffin-embedded neuropathology specimens.
- Author
-
Gorißen C, Albers A, Ruf V, Chteinberg E, Siebert R, Schweizer L, Kaufmann L, Kühn JE, Tappe D, Kuhlmann T, and Thomas C
- Subjects
- Humans, Genome, Viral genetics, Neuropathology methods, Tissue Fixation methods, Formaldehyde, Paraffin Embedding, Whole Genome Sequencing
- Published
- 2024
- Full Text
- View/download PDF
10. Exploring the effects of Merkel cell polyomavirus T antigens expression in REH and MCC13 cells by methylome and transcriptome profiling.
- Author
-
Macamo A, Liu D, Färber M, Borman F, van den Oord J, Winnepenninckx V, Klufah F, Chteinberg E, and Zur Hausen A
- Subjects
- Humans, Cell Line, Tumor, Polyomavirus Infections virology, Polyomavirus Infections genetics, Skin Neoplasms virology, Skin Neoplasms genetics, Epigenome, Merkel cell polyomavirus genetics, DNA Methylation, Carcinoma, Merkel Cell virology, Carcinoma, Merkel Cell genetics, Gene Expression Profiling, Antigens, Viral, Tumor genetics
- Abstract
Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with a tripled incidence in the US and Europe over the past decade. Around 80% of MCC is linked to Merkel cell polyomavirus, but the cell of origin remains unknown. We stably introduced Merkel cell polyomavirus (MCPyV)-sT) and LT antigens to MCC13 and REH cell lines, analyzing DNA methylation and gene transcriptional regulation. Gene ontology analysis assessed MCPyV effects, and integrative analysis correlated gene expression and methylation. Expression patterns were compared with 15 previously sequenced primary MCCs. We found that MCPyV-LT induces DNA methylation changes in both cell lines, while MCPyV-sT only affected REH cells. Greater gene expression changes are observed in MCC13 cells, with upregulated genes associated with cellular components and downregulated genes related to biological processes. Integrative analysis of differentially expressed genes (DEG) and differentially methylated regions (DMR) of REH cell lines revealed that no genes were commonly methylated and differentially expressed. The study compared DEGs and DMG in MCC13 and REH cells to overlapping genes in MCPyV-positive cell lines (MKL1, MKL2, and WaGa), identifying hypomethylated genes in the gene body and hypermethylated genes at TSS1500. GO analysis of the two cell lines showed that MCPyV-TAs can downregulate genes in MHC-I pathways; this downregulation offers a target that can be used to create novel and efficient MCC immunotherapy approaches. Finally, it was confirmed that MCPyV-LT controls gene expression in MCC tissues using an integrative investigation of DNA methylation and gene expression., (© 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
11. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
- Author
-
Künstner A, Schwarting J, Witte HM, Xing P, Bernard V, Stölting S, Lohneis P, Janke F, Salehi M, Chen X, Kusch K, Sültmann H, Chteinberg E, Fischer A, Siebert R, von Bubnoff N, Merz H, Busch H, Feller AC, and Gebauer N
- Subjects
- Humans, Female, Male, Middle Aged, Hematologic Neoplasms genetics, Hematologic Neoplasms pathology, Tumor Microenvironment genetics, Aged, Adult, Prognosis, Gene Expression Regulation, Neoplastic, Mutation, Biomarkers, Tumor genetics, Dendritic Cells pathology, Dendritic Cells metabolism, DNA Methylation
- Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) constitutes a rare and aggressive malignancy originating from plasmacytoid dendritic cells (pDCs) with a primarily cutaneous tropism followed by dissemination to the bone marrow and other organs. We conducted a genome-wide analysis of the tumor methylome in an extended cohort of 45 BPDCN patients supplemented by WES and RNA-seq as well as ATAC-seq on selected cases. We determined the BPDCN DNA methylation profile and observed a dramatic loss of DNA methylation during malignant transformation from early and mature DCs towards BPDCN. DNA methylation profiles further differentiate between BPDCN, AML, CMML, and T-ALL exhibiting the most striking global demethylation, mitotic stress, and merely localized DNA hypermethylation in BPDCN resulting in pronounced inactivation of tumor suppressor genes by comparison. DNA methylation-based analysis of the tumor microenvironment by MethylCIBERSORT yielded two, prognostically relevant clusters (IC1 and IC2) with specific cellular composition and mutational spectra. Further, the transcriptional subgroups of BPDCN (C1 and C2) differ by DNA methylation signatures in interleukin/inflammatory signaling genes but also by higher transcription factor activity of JAK-STAT and NFkB signaling in C2 in contrast to an EZH2 dependence in C1-BPDCN. Our integrative characterization of BPDCN offers novel molecular insights and potential diagnostic applications., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
12. Bovine Meat and Milk Factor-like Sequences Are Frequently Detected in Renal Cell Carcinoma Tissues.
- Author
-
Mobaraki G, Shi S, Smits KM, Severens K, Lommen K, Rennspiess D, Chteinberg E, Winnepenninckx V, Samarska I, Klufah F, and Hausen AZ
- Abstract
Previous studies have indicated a potential role of diet in the pathogenesis of renal cell carcinoma (RCC). Recently, circular bovine meat and milk factor (BMMF) DNAs have been identified in peritumoral tissues of human colon and breast cancers. Here, we investigated the prevalence of the DNA of these novel human pathogenic infectious agents in RCC and adjacent peritumoral renal tissues. DNA was extracted from formalin-fixed and paraffin-embedded (FFPE) RCC and peritumoral kidney tissues, including a test (n = 11) and a validation (n = 152) collection. BMMF1 and BMMF2 consensus primers were designed to screen for the presence of BMMF1- and BMMF2-like DNA. In addition, BMMF-specific PCR was performed on selected cases to test for the presence of additional regions of BMMF1 and BMMF2 genomes. A reference collection of hepatocellular carcinomas (HCCs; n = 60) and adjacent peritumoral liver tissues (n = 50) was also included. Our results demonstrated that BMMF1 and BMMF2 DNAs are frequently found in human RCC tissues and are particularly more prevalent in peritumoral kidney tissues. Of note, BMMF1 and BMMF2 genotype heterogeneity was higher in peritumoral kidney tissues compared to RCC tissues. This is the first study to directly test human FFPE tissues for BMMF1- and BMMF2-like DNA using consensus PCR and demonstrate BMMF DNA in neoplastic and peritumoral kidney tissues. The findings are in line with the recently proposed indirect etiopathogenetic role of BMMFs in, e.g., colorectal carcinogenesis. Follow-up studies are needed to explore the potential role of BMMFs in the etiopathogenesis of RCC.
- Published
- 2024
- Full Text
- View/download PDF
13. Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas.
- Author
-
Witte HM, Künstner A, Chteinberg E, Piazza F, Roué G, and Gebauer N
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
- Published
- 2023
- Full Text
- View/download PDF
14. The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas.
- Author
-
Kouroukli AG, Fischer A, Kretzmer H, Chteinberg E, Rajaram N, Glaser S, Kolarova J, Bashtrykov P, Mathas S, Drexler HG, Ohno H, Ammerpohl O, Jeltsch A, Siebert R, and Bens S
- Subjects
- Humans, DNA Methylation, CpG Islands, Lymphoma, B-Cell genetics, Telomerase genetics, Telomerase metabolism
- Published
- 2023
- Full Text
- View/download PDF
15. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
- Author
-
Broséus J, Hergalant S, Vogt J, Tausch E, Kreuz M, Mottok A, Schneider C, Dartigeas C, Roos-Weil D, Quinquenel A, Moulin C, Ott G, Blanchet O, Tomowiak C, Lazarian G, Rouyer P, Chteinberg E, Bernhart SH, Tournilhac O, Gauchotte G, Lomazzi S, Chapiro E, Nguyen-Khac F, Chery C, Davi F, Hunault M, Houlgatte R, Rosenwald A, Delmer A, Meyre D, Béné MC, Thieblemont C, Lichter P, Ammerpohl O, Guéant JL, Guièze R, Martin-Subero JI, Cymbalista F, Feugier P, Siebert R, and Stilgenbauer S
- Subjects
- Humans, B-Lymphocytes pathology, DNA Methylation genetics, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Leukemia, Lymphocytic, Chronic, B-Cell pathology, Lymphoma, Large B-Cell, Diffuse genetics, Lymphoma, Large B-Cell, Diffuse pathology
- Abstract
Richter syndrome (RS) is the transformation of chronic lymphocytic leukemia (CLL) into aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). We characterize 58 primary human RS samples by genome-wide DNA methylation and whole-transcriptome profiling. Our comprehensive approach determines RS DNA methylation profile and unravels a CLL epigenetic imprint, allowing CLL-RS clonal relationship assessment without the need of the initial CLL tumor DNA. DNA methylation- and transcriptomic-based classifiers were developed, and testing on landmark DLBCL datasets identifies a poor-prognosis, activated B-cell-like DLBCL subset in 111/1772 samples. The classification robustly identifies phenotypes very similar to RS with a specific genomic profile, accounting for 4.3-8.3% of de novo DLBCLs. In this work, RS multi-omics characterization determines oncogenic mechanisms, establishes a surrogate marker for CLL-RS clonal relationship, and provides a clinically relevant classifier for a subset of primary "RS-type DLBCL" with unfavorable prognosis., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
16. T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
- Author
-
Patil P, Hillebrecht S, Chteinberg E, López C, Toprak UH, Seufert J, Bernhart SH, Kretzmer H, Bergmann AK, Bens S, Högel J, Müller A, Jebaraj BM, Schrader A, Johansson P, Costa D, Schlesner M, Dürig J, Herling M, Campo E, Stilgenbauer S, Wiehle L, and Siebert R
- Subjects
- Carcinogenesis genetics, DNA Methylation genetics, Epigenesis, Genetic, Humans, Leukemia, Prolymphocytic, T-Cell genetics, MicroRNAs genetics
- Abstract
Deregulation of micro(mi)-RNAs is a common mechanism in tumorigenesis. We investigated the expression of 2083 miRNAs in T-cell prolymphocytic leukemia (T-PLL). Compared to physiologic CD4+ and CD8+ T-cell subsets, 111 miRNAs were differentially expressed in T-PLL. Of these, 33 belonged to miRNA gene clusters linked to cancer. Genomic variants affecting miRNAs were infrequent with the notable exception of copy number aberrations. Remarkably, we found strong upregulation of the miR-200c/-141 cluster in T-PLL to be associated with DNA hypomethylation and active promoter marks. Our findings suggest that copy number aberrations and epigenetic changes could contribute to miRNA deregulation in T-PLL., (© 2022 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
17. Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro .
- Author
-
Chteinberg E, Wetzels S, Gerritsen W, Temmerman L, van den Oord J, Biessen E, Kurz AK, Winnepenninckx V, Zenke M, Speel EJ, and Zur Hausen A
- Abstract
Background: Merkel cell carcinoma (MCC) is a highly malignant skin cancer. Despite major treatment improvements during the last decade, up to 50% of patients do not respond to therapy or develop recurrent disease. For these patients, alternative treatment options are urgently needed. Here, we assessed the efficacy of the combination of the BCL-2 inhibitor Navitoclax and the PI3K p110α inhibitor Alpelisib in MCC cell lines., Methods: The expression of BCL-2 was assessed by immunohistochemistry in MCC and MCC cell lines. Treatment with Navitoclax and Alpelisib alone and in combination was performed on four MCC cell lines. The decrease of cell viability during treatment was assessed by XTT assay and visualized for the combinations by 3D combinatorial index plotting. The increase of apoptotic cells was determined by cleaved PARP Western blotting and Annexin V staining., Results: Some 94% of MCCs and all three MCPyV-positive cell lines showed BCL-2 expression. Navitoclax monotreatment was shown to be highly effective when treating BCL-2-positive cell lines (IC
50 -values ranging from 96.0 to 323.0 nM). The combination of Alpelisib and Navitoclax resulted in even stronger synergistic and prolonged inhibitions of MCC cell viability through apoptosis up to 4 days., Discussion: Our results show that the anti-apoptotic BCL-2 is frequently expressed in MCC and MCC cell lines. Inhibition of BCL-2 by Navitoclax in combination with Alpelisib revealed a strong synergy and prolonged inhibition of MCC cell viability and induction of apoptosis. The combination of Navitoclax and Alpelisib is a novel potential treatment option for MCC patients., Competing Interests: Declaration of conflicting interest: The authors declare that there is no conflict of interest., (© The Author(s), 2020.)- Published
- 2020
- Full Text
- View/download PDF
18. The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotency.
- Author
-
Chteinberg E, Vogt J, Kolarova J, Bormann F, van den Oord J, Speel EJ, Winnepenninckx V, Kurz AK, Zenke M, Siebert R, and Hausen AZ
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Merkel Cell pathology, Carcinoma, Merkel Cell virology, DNA Methylation, Female, Humans, Male, Merkel cell polyomavirus pathogenicity, Middle Aged, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells physiology, Carcinoma, Merkel Cell genetics, Cellular Senescence, Epigenesis, Genetic, Mutation Accumulation
- Abstract
Merkel cell carcinoma (MCC) is a very rare, but highly aggressive skin cancer which occurs mainly in elderly patients. MCC cells show an expression pattern of three cell lineages: epithelial, neuroendocrine, and B-cell progenitor. This trilinear expression pattern suggests stemness activity in MCC. The etiopathogenesis of MCC is either linked to the Merkel cell polyomavirus (MCPyV) or in a smaller proportion (20%) to high levels of UV-induced somatic mutations. Both viral presence and accumulation of mutations have been shown to be associated with accelerated DNA methylation Age (DNAmAge) compared to chronological age. The MCC DNAmAge was significantly lower compared to the chronological age, which was irrespective of the viral presence or mutational burden. Although these features indicate some aspects of stemness in MCC cells, gene-expression-based pluripotency testing did not provide evidence for pluripotency of MCC cells.
- Published
- 2020
- Full Text
- View/download PDF
19. High Prevalence of Human Polyomavirus 7 in Cholangiocarcinomas and Adjacent Peritumoral Hepatocytes: Preliminary Findings.
- Author
-
Klufah F, Mobaraki G, Chteinberg E, Alharbi RA, Winnepenninckx V, Speel EJM, Rennspiess D, Olde Damink SW, Neumann UP, Kurz AK, Samarska I, and Zur Hausen A
- Abstract
Cholangiocarcinoma (CCA) is a rare biliary-duct malignancy with poor prognosis. Recently, the presence of the human polyomavirus 6 (HPyV6) has been reported in the bile of diverse hepatobiliary diseases, particularly in the bile of CCA patients. Here, we investigated the presence of novel HPyVs in CCA tissues using diverse molecular techniques to assess a possible role of HPyVs in CCA. Formalin-Fixed Paraffin-Embedded (FFPE) tissues of 42 CCA patients were included in this study. PCR-based screening for HPyVs was conducted using degenerated and HPyV-specific primers. Following that, we performed FISH, RNA in situ hybridization (RNA-ISH), and immunohistochemistry (IHC) to assess the presence of HPyVs in selected tissues. Of all 42 CCAs, 25 (59%) were positive for one HPyV, while 10 (24%) CCAs were positive for 2 HPyVs simultaneously, and 7 (17%) were negative for HPyVs. Of the total 35 positive CCAs, 19 (45%) were positive for HPyV7, 4 (9%) for HPyV6, 2 (5%) for Merkel cell polyomavirus (MCPyV), 8 (19%) for both HPyV7/MCPyV, and 2 (5%) for both HPyV6/HPyV7 as confirmed by sequencing. The presence of viral nucleic acids was confirmed by specific FISH, while the RNA-ISH confirmed the presence of HPyV6 on the single-cell level. In addition, expression of HPyV7, HPyV6, and MCPyV proteins were confirmed by IHC. Our results strongly indicate that HPyV7, HPyV6, and MCPyV infect bile duct epithelium, hepatocytes, and CCA cells, which possibly suggest an indirect role of these viruses in the etiopathogenesis of CCA. Furthermore, the observed hepatotropism of these novel HPyV, in particular HPyV7, might implicate a role of these viruses in other hepatobiliary diseases.
- Published
- 2020
- Full Text
- View/download PDF
20. Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors.
- Author
-
Chteinberg E, Klufah F, Rennspiess D, Mannheims MF, Abdul-Hamid MA, Losen M, Keijzers M, De Baets MH, Kurz AK, and Zur Hausen A
- Subjects
- Adult, Aged, Aged, 80 and over, Animals, Carcinogenesis genetics, Female, Gene Expression Regulation, Neoplastic genetics, Humans, In Situ Hybridization, Fluorescence methods, Male, Merkel cell polyomavirus pathogenicity, Mice, Middle Aged, Neoplasms, Glandular and Epithelial epidemiology, Neoplasms, Glandular and Epithelial pathology, Neoplasms, Glandular and Epithelial virology, Thymoma epidemiology, Thymoma pathology, Thymoma virology, Thymus Neoplasms epidemiology, Thymus Neoplasms pathology, Thymus Neoplasms virology, Merkel cell polyomavirus genetics, Neoplasms, Glandular and Epithelial genetics, Thymoma genetics, Thymus Neoplasms genetics, Viral Proteins genetics
- Abstract
Background: The etiology of thymic epithelial tumors is unknown. Murine polyomavirus strain PTA has been shown to induce thymomas in mice. Recently, using diverse molecular techniques, we reported the presence of human polyomavirus 7 (HPyV7) in thymic epithelial tumors. In the present study, we investigated the prevalence of Merkel cell polyomavirus (MCPyV) in thymic epithelial tumors., Methods: Thirty-six thymomas were screened for MCPyV by PCR and subsequently tested by DNA and RNA in situ hybridization and immunohistochemistry. Twenty-six thymomas were diagnosed with myasthenia gravis (MG)., Results: MCPyV DNA was detected by PCR in 7 (19.4%) of the 36 thymic epithelial tumors and in six of these, the presence of MCPyV was confirmed by fluorescence situ hybridization. Of these, 3 (28.6%) revealed weak MCPyV LT-antigen protein expression. In addition, one of the MCPyV positive thymomas tested positive for MCPyV LT RNA with RNAscope. Of interest, two out of the three thymomas that previously tested positive for MCPyV by immunohistochemistry also tested positive for HPyV7. One of the 11 MG-negative and 2 of the 25 MG-positive were positive for MCPyV., Conclusions: MCPyV DNA and MCPyV protein expression can be detected in human epithelial thymoma; however, to a far lesser extent than HPyV7. Our data strongly indicate that because of its infrequent detection and weak expression, MCPyV is unlikely to play an important role in the etiopathogenesis of human thymomas., (© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
21. Neuroendocrine Key Regulator Gene Expression in Merkel Cell Carcinoma.
- Author
-
Chteinberg E, Sauer CM, Rennspiess D, Beumers L, Schiffelers L, Eben J, Haugg A, Winnepenninckx V, Kurz AK, Speel EJ, Zenke M, and Zur Hausen A
- Subjects
- Aged, Aged, 80 and over, Basic Helix-Loop-Helix Transcription Factors genetics, Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Line, Tumor, DNA Methylation, Female, Gene Expression, Humans, Immunohistochemistry, Male, Merkel cell polyomavirus metabolism, MicroRNAs genetics, Middle Aged, Promoter Regions, Genetic, RNA Interference, RNA, Small Interfering genetics, Repressor Proteins genetics, Repressor Proteins metabolism, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Merkel cell polyomavirus genetics
- Abstract
Merkel cell carcinoma (MCC) is a highly aggressive non-melanoma skin cancer of the elderly which is associated with the Merkel cell polyomavirus (MCPyV). MCC reveals a trilinear differentiation characterized by neuroendocrine, epithelial and pre/pro B-cell lymphocytic gene expression disguising the cellular origin of MCC. Here we investigated the expression of the neuroendocrine key regulators RE1 silencing transcription factor (REST), neurogenic differentiation 1 (NeuroD1) and the Achaete-scute homolog 1 (ASCL1) in MCC. All MCCs were devoid of REST and were positive for NeuroD1 expression. Only one MCC tissue revealed focal ASCL1 expression. This was confirmed in MCPyV-positive MCC cell lines. Of interest, MCPyV-negative cell lines did express REST. The introduction of REST expression in REST-negative, MCPyV-positive MCC cells downregulated the neuroendocrine gene expression. The lack of the neuroendocrine master regulator ASCL1 in almost all tested MCCs points to an important role of the absence of the negative regulator REST towards the MCC neuroendocrine phenotype. This is underlined by the expression of the REST-regulated microRNAs miR-9/9* in REST-negative MCC cell lines. These data might provide the basis for the understanding of neuroendocrine gene expression profile which is expected to help to elucidate the cellular origin of MCC., (Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
22. Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma.
- Author
-
Chteinberg E, Rennspiess D, Sambo R, Tauchmann S, Kelleners-Smeets NWJ, Winnepenninckx V, Speel EJ, Kurz AK, Zenke M, and Zur Hausen A
- Abstract
The prognosis of stage III/IV Merkel cell carcinoma (MCC) is very poor. The Phosphatidylinositol 3-kinase p110δ specific inhibitor idelalisib has recently been reported to induce complete clinical remission in a stage IV MCC patient. Here we assessed the expression of p110δ in primary MCC and MCC cell lines including its functionality. Immunofluorescence microscopy revealed a specific cytoplasmic p110δ expression in 71.4% of the tested MCCs and in all tested MCC cell lines. Compared to the B cell leukemia cell line REH all MCC cell lines, except MKL-1, revealed a lower response towards the treatment with idelalisib. MKL-1 showed a 10-fold higher IC
50 compared to REH which was accompanied by a significant decrease of Akt phosphorylation. However, treating the MCC cells with the specific PI3K p110α subunit inhibitor BYL719 led to a more effective decrease of the cell viability compared to idelalisib: WaGa cells 30-fold, PeTa cells 15-fold and all other MCC cell lines 3-fold. Although PI3K p110δ is expressed in the majority of MCCs and cell lines its inhibition by idelalisib alone does not suffice to effectively affect MCC cells viability., Competing Interests: CONFLICTS OF INTEREST The authors declare no conflicts of interest.- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.